WCN 2024
WCN 2024
Advertisement
Charlotte RobinsonWCN 2024 | April 30, 2024
Interim analysis from the APPLAUSE-IgAN trial found favorable results for the use of iptacopan in IgAN.
Read More
Charlotte RobinsonWCN 2024 | April 20, 2024
A super-learner strategy gave accurate risk predictions of kidney failure and death for people with moderate to severe CKD.
Charlotte RobinsonWCN 2024 | April 19, 2024
Longer follow-up results of the RUBY-3 trial found povetacicept is well-tolerated and shows promise for IgAN treatment.
Charlotte RobinsonWCN 2024 | April 19, 2024
Researchers uncovered clinical and economic of the Kidney BEAM physical activity digital health intervention for CKD.
Charlotte RobinsonWCN 2024 | April 18, 2024
Researchers found that sparsentan had a clinically meaningful benefit on long-term kidney preservation versus irbesartan.
Charlotte RobinsonWCN 2024 | April 18, 2024
Researchers studied the prevalence of hyperkalemia in patients at a facility in Durban, South Africa.
Charlotte RobinsonWCN 2024 | May 23, 2024
Researchers reported on real-world use of SZC for hyperkalemia in a cohort of Asian hemodialysis patients.
Charlotte RobinsonWCN 2024 | April 17, 2024
A simulation model predicts a dramatic increase in the impact of chronic kidney disease in the next 10 years.
Advertisement
Advertisement
Advertisement
Latest News

July 16, 2024